Appendix 1. Writing Group Disclosures

Appendix 1. Writing Group Disclosures
Writing Group Member Employment Research Grant Other Research Support Speakers' Bureau/
Honoraria
Expert Witness Ownership Interest Consultant/
Advisory Board
Other
Khalid Aziz University of Alberta Pediatrics None None None None None None University of Alberta†
Henry C. Lee Stanford University NICHD (PI of R01 grant examining intensive care for infants born at extremely early gestational age)* None None None None None None
Marilyn B. Escobedo University of Oklahoma Medical School Pediatrics None None None None None None None
Amber V. Hoover American Heart Association None None None None None None None
Beena D. Kamath-Rayne American Academy of Pediatrics None None None None None None None
Vishal S. Kapadia UT Southwestern Pediatrics NIH, NICHD† None None None None None None
David J. Magid University of Colorado NIH†; NHLBI†; CMS†; AHA† None None None None None American Heart Association (Senior Science Editor)†
Susan Niermeyer University of Colorado Pediatrics None None None None None None None
Georg M. Schmölzer University of Alberta Pediatrics Heart and Stroke Foundation Canada*; Canadian Institute of Health Research*; THRASHER Foundation*; Canadian Institute of Health Research* None None None Owner of RETAIN LABS Medical Inc.* None None
Edgardo Szyld University of Oklahoma None None None None None None None
Gary M. Weiner University of Michigan Pediatrics-Neonatology None None None None None None None
Myra H. Wyckoff UT Southwestern Pediatrics None None None None None None None
Nicole K. Yamada Stanford University AHRQ† None None None None None None
Jeanette Zaichkin Self used None None None None None American Academy of Pediatrics Neonatal Resuscitation Program† None

This table represents the relationships of writing group members that may be perceived as actual or reasonably perceived conflicts of interest as reported on the Disclosure Questionnaire, which all members of the writing group are required to complete and submit. A relationship is considered to be “significant” if (a) the person receives $10 000 or more during any 12-month period, or 5% or more of the person’s gross income; or (b) the person owns 5% or more of the voting stock or share of the entity, or owns $10000 or more of the fair market value of the entity. A relationship is considered to be “modest” if it is less than “significant” under the preceding definition.

*Modest.
†Significant.